Hidden Goals and Illness

After I shared earlier this week about hidden goals, a lot of news came out about more people getting infected with the coronavirus. This includes people who deliberately went against sensible health guidelines, especially regarding mask wearing

From a cause-and-effect perspective, we could say that the virus eventually caught up with them, and of course their risky behaviors significantly increased their chances of getting infected.

But from a hidden goals perspective, we can also say that when people express such behaviors, they’re also expressing the hidden goal of getting infected. In other words, not wearing a mask isn’t just an expression of denial or bravado. Not wearing a mask expresses an elevated intention to invite infection. The hidden goal is to get sick.

Why would someone – or some part of a person’s psyche – want to get infected?

There could be lots of reasons. What are the benefits of getting infected? These are numerous.

First, you get immediate access to lots of downtime in a socially acceptable way. You’re expected to go into isolation and rest more.

Suppose that I announced that I had the virus. Wouldn’t that immediately change what you expected of me in the coming weeks? If I put myself into such a stressful or obligatory situation that getting sick could provide a much needed break, that could increase my chances of engaging in risky behaviors, such as not exercising or not eating well.

How often have you gotten sick when you were stressed, but you could also look back and see that you didn’t take very good care of yourself during those times either? Did you eat more iffy foods or slack off on good self-care practices? If so, you could say that you were courting illness as a way of giving yourself a break.

If you’re a very busy person and say you just want two weeks off for the sake of taking two weeks off, how will your social circle respond to that? Will anyone give you flak for it? How would they respond if you needed a few weeks off due to a serious or life-threatening illness?

If you get sick, the time is yours, and people are normally glad to let you off the hook regarding any expectations. They just expect you to focus on recovery.

Trump’s situation could also align well with hidden goals. He’s heading for an election that he’s likely to lose. He had a terrible debate performance this past week and has two more debates coming up (with the expectation of tighter rules), so there’s little or no upside and lots of downside if he does them. His long-term financial lies have been exposed publicly by the New York Times. He’s facing huge debt payments coming due, and he’s dealing with a major audit from this IRS that could cost him $100 million or so. More ex-insiders are turning against him. He and his family members may be looking at some real jail time too. Suffice it to say that his world is collapsing, and he doesn’t have many good options going forward.

His previous approach included trying to disrupt the election, setting the stage for disputing the results and throwing the process into chaos. That creates a big mess, but it probably wouldn’t work well enough to actually solve his problems, and this is generating an even bigger backlash against him.

By some measures it may seem like this would be the worst time for him to get sick – with just a month to go until the election. At a bare minimum, he has to self-isolate for at least 10 days, which is 1/3 of the time he has left. And that’s if things go well and he recovers quickly, which seems iffy since he just spent last night in the hospital.

But from the perspective of hidden goals, this is actually a very good time for him to get sick. As odd as it may seem, getting sick provides more options during this time.

He’s losing anyway. The next two debates aren’t going to go well for him, especially if they turn off his mic while Biden is speaking. He’s unlikely to turn things around in the next 30 days. There isn’t much hope for him to be found in those 30 days if he stays healthy. Even if he does his absolute best, it won’t likely make enough of a difference.

But getting sick – at a minimum – gives him access to extra outs and reframes. I’m not sure which of those would appeal to him, and some depend on how sick he gets, but here are a few to consider.

One aspect is that he gets to blame the virus if he loses – and anyone and anything he can associate with it. Moreover, people’s expectations of his performance are greatly lowered. So he can lose the election without losing so much of his social support. His supporters get to blame the virus too, and he surely knows this.

Another angle is that if he recovers quickly, he can say that the virus isn’t such a big deal and that people are blowing it out of proportion. Or he could claim that he’s strong enough to beat it quickly. And then if he loses the election, he can still blame the virus (and all of its associations) for its bad timing during the final month before the election. But given his hospitalization, I think this angle regarding a speedy recovery is becoming less accessible.

Another angle is that if he gets really sick, he can try to make a case for postponing the election. It fits with his attempts to sabotage the election and gives him even more options along those lines.

There’s also the angle of the virus being potentially fatal. That too is a potential hidden goal – the ultimate escape from all of life’s problems and challenges. Just let everything go and be done with it.

These are just conjectures since we can’t really know what another person’s hidden goals may be. I share this for the purpose of encouraging you to look at your own hidden goals – the goals that can be gleaned from your actual behaviors. So don’t see hidden goals as some absolute truth you’re trying to discover about yourself (or about other people). Rather see this as a tool that you can use to better understand your behavior and where you may be heading, so you can make more conscious choices.

If you play fast and loose with intelligent health precautions these days, consider the potential hidden goal that you may be trying to get sick. Then ask why you might want to do that. Do you see any potential benefits to a period of illness?

Illness can provide many benefits. It’s a period of rest. People’s expectations are immediately lowered, so it can make life easier, especially socially. You may be treated with more caring and compassion. Many of your problems will be put on pause – and some may even be improved or solved by your illness, such as interpersonal problems. An illness can remind you to appreciate good health and how precious it is, so you feel extra good when you recover.

Have you ever gotten sick in the past and found afterwards that it wasn’t such a bad thing? The experience may not be so great, but when you look at the full package, it’s not necessarily all bad.

The lesson of hidden goals with respect to illness is this: Watch out for when getting sick might actually give you some nice benefits or more options – especially when you see your behavior sliding in the direction of courting illness, like Trump’s behavior has been for months. That’s a good time to acknowledge the hidden goal and give it some conscious expression instead. You don’t have to court illness to get those benefits. You can create those benefits in other ways.

If you suspect that based on your behaviors, you may be courting illness, consider that you’re actually dealing with a social problem. If you lived alone on an island, you wouldn’t need to get sick just to earn a break from people’s expectations. So the warning signs of courting illness can point towards the need to invest in better management of social boundaries and expectations and win-win relationships.

You can also see this as a lifestyle problem. If illness starts to look better than wellness, at least to give you access to a short period of rest, that signals that your lifestyle is out of balance and that it would be wise to incorporate more rest. You can claim a lifestyle that includes sufficient time for rest and play. Maintain a lifestyle that provides an accessible pathway to the benefits of illness without actually having to get sick.

Share Button

Virtual follow-up care is more convenient and just as beneficial to surgical patients

Surgical patients who participate in virtual follow-up visits after their operations spend a similar amount of time with surgical team members as those who meet face-to-face. Moreover, these patients benefit by spending less time waiting at and traveling to the clinic for in-person appointments, according to research findings presented at the virtual American College of Surgeons Clinical Congress 2020.

“I think it’s really valuable for patients to understand that, in the virtual space scenario, they are still going to get quality time with their surgical team,” said lead study author Caroline Reinke, MD, FACS, associate professor of surgery at Atrium Health in Charlotte, N.C. “A virtual appointment does not shorten that time, and there is still an ability to answer questions, connect, and address ongoing medical care.”

Due to the Coronavirus Disease 2019 (COVID-19) pandemic and the widespread adoption of technology, many surgical patients are being offered virtual appointments in place of traditional in-person visits. The researchers say this is one of the first studies to look at how patients spend their time in post-operative virtual visits compared with face-to-face consultations.

The study design was a non-inferiority, randomized controlled trial that involved more than 400 patients who underwent laparoscopic appendectomy or cholecystectomy at two hospitals in Charlotte, N.C. and were randomized 2:1 to a post-discharge virtual visit or to an in-person visit. The study began in August 2017 but was put on hold in March 2020 due to COVID-19.

“Other studies have looked at the total visit time, but they haven’t been able to break down the specific amount of time the patient spends with the provider. And we wanted to know if that was the same or different between a virtual visit and an in-person visit,” Dr. Reinke said. “We wanted to get down to the nitty gritty of how much face time was actually being spent between the surgical team member and the patient.”

Researchers tracked total time the patients spent checking in, waiting in the waiting room and exam room, meeting with the surgical team member, and being discharged after the exam. For in-person visits, on-site waiting time and an estimated drive time was factored into the overall time commitment.

Just 64 percent of patients completed the follow-up visit. “Sometimes, patients are doing so well after minimally invasive surgery that about 30 percent of these patients don’t show up for a post-operative visit,” Dr. Reinke said.

Overall, results showed that the total clinic time was longer for in-person visits than virtual visits (58 minutes vs. 19 minutes). However, patients in both groups spent the same amount of face time with a member of their surgical team (8.3 minutes vs. 8.2 minutes) discussing their post-operative recovery.

“I was pleasantly surprised that the amount of time patients spent with the surgical team member was the same, because one of the main concerns with virtual visits is that patients feel disconnected and that there isn’t as much value in it,” Dr. Reinke said.

Importantly, patients placed a high value on convenience and flexibility. “We received overwhelmingly positive responses to this patient-centered care option.” Dr. Reinke said. “Patients were able to do the post-operative visit at work or at home while caring for children, without having to disrupt their day in such a significant way.”

The researchers also found that patients embraced the virtual scenario. The satisfaction rate between both groups of patients was similar (94 percent vs. 98 percent).

In addition, wait time was much less for patients who got virtual care. “Even for virtual visits, the amount of time the patients spent checking in and waiting was about 55 percent of total time. Because virtual visits have the same regulations as in-person visits, even if you take out the components of waiting room and patient flow within the clinic, patients are still spending about half of their time on the logistics of check in,” Dr. Reinke. “Yet, with virtual visits, there is still much less time spent waiting, about 80 percent less time.”

Still, some patients are not comfortable with the technology. The number of patients who couldn’t or didn’t want to do a virtual visit was higher than expected, according to the authors.

“I think there are some patients that would really just rather come in and shake someone’s hand,” Dr. Reinke said. “I think for surgery it’s a little bit different, because with surgical care there are incisions to check on. However, we were able to check on incisions pretty easily, having patients show us their incisions virtually on the video screen.”

This research was supported by the American College of Surgeons Franklin H. Martin Faculty Research Fellowship. “FACS” designates that a surgeon is a Fellow of the American College of Surgeons.

Citation: The Value of Time: Analysis of Surgical Post-Discharge Virtual vs. In-Person Visits. Scientific Forum, American College of Surgeons Clinical Congress 2020, October 3-7, 2020.

Share Button

Covid: Faith groups’ singing studied for coronavirus risk

The findings could be used to shape government guidance on safe use of places of worship.

Share Button

Harvesting vegetation on riparian buffers barely reduces water-quality benefits

Allowing farmers to harvest vegetation from their riparian buffers will not significantly impede the ability of those streamside tracts to protect water quality by capturing nutrients and sediment — and it will boost farmers’ willingness to establish buffers.

That is the conclusion of Penn State College of Agricultural Sciences researchers, who compared the impacts of six riparian buffer design scenarios over two, four-year crop rotations in two small central and southeastern Pennsylvania watersheds. Two of the buffer scenarios included the harvesting of switchgrass and swamp willow trees.

Allowing farmers to harvest vegetation from their riparian buffers and sell it for biofuels — not permitted under current Conservation Reserve Enhancement Program, or CREP, federal regulations — would go a long way toward persuading farmers to establish riparian buffers, researchers contend. And farmers’ buy-in is badly needed in Pennsylvania, where hundreds of miles of new buffers are needed along streams emptying into the Chesapeake Bay to help the state meet water-quality standards.

“This is the first long-term study in the Chesapeake Bay watershed to model how harvesting vegetation affects riparian buffer performance over the full length of a buffer contract,” said researcher Heather Preisendanz, associate professor of agricultural and biological engineering. “Allowing harvesting of the buffer vegetation — either trees or grasses — minimally impacted water quality, with only slight annual average reductions in the capture of nitrogen, phosphorus and sediment.”

In addition, she noted, under the highest input loading conditions — heavy runoff after storms — buffers with lower removal efficiencies removed more total mass of pollutants than did buffers with high-removal efficiencies, if they were between streams and fields with row crops such as corn and soybeans. The location of the buffer was most important.

The researchers, who modeled runoff and resulting pollution from agricultural fields reaching the streams, studied riparian buffer performance on Spring Creek in Centre County and Conewago Creek in Lancaster County. Buffer design scenarios studied included 35-feet-wide grass; 50-feet-wide grass; 50-feet-wide deciduous trees; 100-feet-wide grass and trees; 100-feet-wide grass and trees, with trees harvested every three years; and 100-feet-wide grass and trees, with grass harvested every year.

The research team developed these scenarios after considering feedback from focus group meetings with farmers in the two watersheds. Farmers indicated they wanted to be able to install buffers tailored to their properties with the prospect of generating limited revenue.

In the Spring Creek watershed — which has been studied closely by Penn State agricultural scientists for decades — 16 years of daily-scale nutrient and sediment loads from three crop rotations and two soils were simulated in a soil and water assessment tool. That data was used as an input to a riparian ecosystem management model used nationally to better understand how a buffer’s effectiveness changes as a function of input load, buffer design and buffer management.

The simulation results, recently published in the Journal of Environmental Quality, suggest that for buffers of the same width, the farmer-preferred grass vegetation outperformed policy-preferred vegetation of trees for sediment, nitrogen and phosphorus removal.

The findings of the research have important implications for informing flexible buffer design policies and enhanced placement of buffers in watersheds impaired by nutrient and sediment, Preisendanz explained. She pointed out, however, that more research may be needed to examine tradeoffs between water-quality impacts and other ecosystem services, such as streambank stabilization, habitat and stream shading.

“If incorporated into policy, these findings could remove one barrier to farmer adoption of riparian buffers,” she said. “Based on our conversations with famers in focus groups, we think this approach — government being more flexible with buffer designs and allowing harvesting — would go a long way toward farmers agreeing to create more riparian buffers.”

The state Department of Conservation and Natural Resources currently is promoting “multifunctional” buffers, Preisendanz added. “Our hope is that this work will help to inform tradeoffs of flexible buffer designs and management options in this new program.”

Story Source:

Materials provided by Penn State. Original written by Jeff Mulhollem. Note: Content may be edited for style and length.

Share Button

New COVID test doesn’t use scarce reagents, catches all but the least infectious

A major roadblock to large scale testing for coronavirus infection in the developing world is a shortage of key chemicals, or reagents, needed for the test, specifically the ones used to extract the virus’s genetic material, or RNA.

A team of scientists at the University of Vermont, working in partnership with a group at the University of Washington, has developed a method of testing for the COVID-19 virus that doesn’t make use of these chemicals but still delivers an accurate result, paving the way for inexpensive, widely available testing in both developing countries and industrialized nations like the United States, where reagent supplies are again in short supply.

The method for the test, published Oct. 2 in PLOS Biology, omits the step in the widely used reverse transcription polymerase chain reaction (RT-PCR) test where the scarce reagents are needed.

92% accuracy, missing only lowest viral loads

The accuracy of the new test was evaluated by a team of researchers at the University of Washington led by Keith Jerome, director of the university’s Molecular Virology Lab, using 215 COVID-19 samples that RT-PCR tests had shown were positive, with a range of viral loads, and 30 that were negative.

It correctly identified 92% of the positive samples and 100% of the negatives.

The positive samples the new test failed to catch had very low levels of the virus. Public health experts increasingly believe that ultra-sensitive tests that identify individuals with even the smallest viral loads are not needed to slow spread of the disease.

“It was a very positive result,” said Jason Botten, an expert on pathogenic RNA viruses at the University of Vermont’s Larner College of Medicine and senior author on the PLOS Biology paper. Botten’s colleague Emily A. Bruce is the paper’s first author.

“You can go for the perfect test, or you can use the one that’s going to pick up the great majority of people and stop transmission,” Botten said. “If the game now is focused on trying to find people who are infectious, there’s no reason why this test shouldn’t be front and center, especially in developing countries where there are often limited testing programs because of reagent and other supply shortages.”

Skipping a step

The standard PCR test has three steps, while this simpler version of the standard test has only two, Botten said.

“In step 1 of the RT-PCR test, you take the swab with the nasal sample, clip the end and place it in a vial of liquid, or medium. Any virus on the swab will transfer from the swab into the medium,” he said. “In step 2, you take a small sample of the virus-containing medium and use chemical reagents, the ones that are often in short supply, to extract the viral RNA. In step 3, you use other chemicals to greatly amplify any viral genetic material that might be there. If virus was present, you’ll get a positive signal.”

The new test skips the second step.

“It takes a sample of the medium that held the nasal swab and goes directly to the third, amplification step,” Botten said, removing the need for scarce RNA extraction reagents as well as significantly reducing the time, labor and costs required to extract viral RNA from the medium in step 2.

Botten said the test is ideally suited to screening programs, in both developed and developing countries, since it is inexpensive, takes much less processing time and reliably identifies those who are likely to spread the disease.

Its low cost and efficiency could extend testing capacity to groups not currently being tested, Botten said, including the asymptomatic, nursing home residents, essential workers and school children. The standard RT-PCR test could be reserved for groups, like health care workers, where close to 100% accuracy is essential.

An influential pre-print points way to widespread adoption of test

The two-step test developed by the University of Vermont team first caught the attention of the scientific community in March, when preliminary results that accurately identified six positive and three negative Vermont samples were published as a preprint in bioRxiv, an open access repository for the biological sciences. The preprint was downloaded 18,000 times — in its first week, it ranked 17th among 15 million papers the site had published — and the abstract was viewed 40,000 times.

Botten heard from labs around the world who had seen the preprint and wanted to learn more about the new test.

“They said, ‘I’m from Nigeria or the West Indies. We can’t test, and people’s lives are at stake. Can you help us?'”

Botten also heard from Syril Pettit, the director of HESI, the Health and Environmental Sciences Institute, a non-profit that marshals scientific expertise and methods to address a range of global health challenges, who had also seen the preprint.

Pettit asked Botten to join a think tank of likeminded scientists she was organizing whose goal was to increase global testing capacity for COVID-19. The test developed by the University of Vermont and University of Washington teams would serve as a centerpiece. To catalyze a global response, the group published a call to action in EMBO Molecular Medicine.

And it took action, reaching out to 10 laboratories in seven countries, including Brazil, Chile, Malawi, Nigeria and Trinidad/Tobago, as well as the U.S. and France, to see if they would be interested in giving the two-step test a trial run. “Universally, the response was yes,” Pettit said.

The outreach led to a new HESI program called PROPAGATE. Each of the labs in the PROPAGATE Network will use the two-step test on a series of positive and negative samples sent to them by the University of Washington to see if they can replicate the results the university achieved.

The study has already shown promising results. One of the labs in Chile has also used the test on its own samples from the community and got accurate results.

Assuming all goes well, Pettit and her colleagues at the University of Vermont and the University of Washington as well as scientists from the 10 partner sites plan to publish the results.

“The goal is the make the two-step test accessible to any lab in the world facing these hurdles and see a broad uptake,” she said.

Share Button

New research sheds light on the reluctance of farmers to adopt new technologies

Research from the University of Kent’s School of Economics sheds new light on a long-standing obstacle to improving agricultural productivity in developing countries: the reluctance of small-scale farmers to adopt modern technologies because of the risks associated with them.

The paper, published in Science Direct, examined the relationship between attitudes towards risk among small-scale aquafarmers in Ghana and the time they take to adopt new technologies that reduce traditional risks, including; poor weather conditions, aquatic predators and poor hygiene.

The researchers conducted a series of psychological experiments with aquafarmers in 30 villages in four regions in southern Ghana to measure their aversion to risk and willingness to take gambles. They also recorded the aquafarmers’ adoption of three innovative technologies recently introduced to Ghana: predator-proof floating cages for fish; a nutrient-rich fish feed; and a fast-growing, disease-resistant breed of tilapia fish.

Results showed that aversion to traditional production risks accelerated the adoption of all three technologies. However, adoption of floating cages was slower due to the significant upfront financial investment required, making small-scale experimentation with the technology impractical. The study also found that once aquafarmers in a community have started using the cages, the aversion by others to take the risk was further reduced.

Based on their findings, the study’s authors advocate providing practical information about new agricultural technologies and information about positive returns from their adoption with the help and encouragement of regional extension agents to encourage the adoption of new agricultural technologies by small-scale farmers in developing countries.

Dr Adelina Gschwandtner, Senior Lecturer in Economics and Principle Investigator, said: ‘These findings may have significant consequences beyond Africa and onto the global agricultural sector. Addressing traditional perceptions with this new understanding of the potential to reduce risk by adopting new ideas, methods, and technologies, may broaden how business ventures are viewed and conducted in the future. This in turn may help agricultural ventures in developing nations become secure and allow them to flourish.’

Story Source:

Materials provided by University of Kent. Original written by Sam Wood. Note: Content may be edited for style and length.

Share Button

Biomedical sciences researchers find new way to prevent and cure rotavirus, other viral infections

A combination of two substances secreted by the immune system can cure and prevent rotavirus infection, as well as potentially treat other viral infections that target epithelial cells, which cover body surfaces such as skin, blood vessels, organs and the urinary tract, according to researchers in the Institute for Biomedical Sciences at Georgia State University.

Rotavirus, which causes severe, life-threatening diarrhea in young children and moderate gastrointestinal distress in adults, leads to thousands of deaths in children annually, particularly in developing countries where rotavirus vaccines are only moderately effective. Rotavirus is an RNA virus that primarily infects intestinal epithelial cells.

The substances identified in the study, officially known as cytokines, are interleukin 18 (IL-18) and interleukin 22 (IL-22). IL-18 and IL-22 are produced when the body detects a protein in the whip-like appendage of bacteria.

The study, which investigated how these cytokines inhibit rotavirus infection, found when mice were treated with both IL-18 and IL-22, the cytokines promoted each other’s expression, but also impeded rotavirus by independent, distinct mechanisms that involved activating receptors in intestinal epithelial cells. These actions resulted in rapid and complete expulsion of rotavirus, even in hosts with severely compromised immune systems. The therapy was also found to be effective for norovirus, a contagious virus that causes vomiting and diarrhea. The findings are published in the journal Science Immunology.

“Our study reports a novel means of eradicating a viral infection, particularly viruses that infect epithelial cells,” said Dr. Andrew Gewirtz, senior author of the study and a professor in the Institute for Biomedical Sciences at Georgia State. “The results suggest that a cocktail that combines IL-18 and IL-22 could be a means of treating viral infections that target short-lived epithelial cells with high turnover rates.”

The study is funded by grants from the National Institutes of Health.

Story Source:

Materials provided by Georgia State University. Note: Content may be edited for style and length.

Share Button

Personalized cancer therapy improves outcomes in advanced disease

Patients receiving care for advanced cancer at Moores Cancer Center at UC San Diego Health were more likely to survive or experience a longer period without their disease progressing if they received personalized cancer therapy, report University of California San Diego School of Medicine researchers.

Led by Razelle Kurzrock, MD, director of the Center for Personalized Cancer Therapy at Moores Cancer Center and senior author of the study, a multidisciplinary molecular tumor board was established to advise treating physicians on course of care using an individual patient’s molecular tumor makeup to design precision medicine strategies.

“Patients who underwent a molecular tumor board-recommended therapy were better matched to genomic alterations in their cancer and had improved outcomes,” said Kurzrock. “The three-year survival for patients with the highest degree of matching and who received a personalized cancer therapy was approximately 55 percent compared to 25 percent in patients who received therapy that was unmatched or had low degrees of matching.”

Of 429 patients evaluated by the molecular tumor board, 62 percent were matched to at least one drug, report the researchers in the October 2, 2020 online issue of Nature Communications. Twenty percent of patients matched to all recommended drugs, including combination therapies.

The tumor board acted in an advisory role and treating physicians chose not to use the board’s recommended strategy in 38 percent of cases, opting instead for a standard therapy approach that might have been unmatched to the patient’s genetic alterations or had a low degree of matching. These patients experienced a lower progression-free survival and overall survival rates.

The use of next-generation sequencing allows for the identification of novel potential targets for patients with cancer to improve outcomes, but there are challenges to using this approach widely, said Shumei Kato, MD, associate professor of medicine at UC San Diego School of Medicine and first author.

“One of the hurdles is that every cancer patient appears to be carrying different molecular and genomic patterns despite having the same cancer type,” said Kato, a Moores Cancer Center medical oncologist specializing in rare and gastrointestinal cancers. “This can be challenging since we are customizing therapy based on the unique genomic pattern patients have, and thus it is difficult to predict the response. In addition, this approach requires multidisciplinary expertise as well as access to drugs or clinical trials not always available in smaller practices.”

Story Source:

Materials provided by University of California – San Diego. Original written by Yadira Galindo. Note: Content may be edited for style and length.

Share Button

Time Logging Insights

For the month of September, I maintained a daily time log, as described in the post called Long-Term Time Logging. Now I can share some insights from what I learned.

In this case it actually wasn’t that helpful to see where my time went. I was pretty aware of that already, so reviewing the logs didn’t give me many insights there. My logs matched up pretty closely with my assumptions and expectations.

What was surprising was what gave me the most joy. At the end of each day, I asked a simple question and briefly answered it at the bottom of the day’s time log. That question was:

Do I love this day?

I had assumed that by asking this question, it would help me become aware of which days I felt best about, and then I could deliberately embrace more of those positive patterns. That turned out to be true, but the surprising part was what actually created a day I loved versus a day I didn’t love.

I figured going into this that I’d love my most productive days. If I got a lot of work done, that should give me a sense of accomplishment, and then I’d feel great at the end of the day, right?

Wrong actually. My most productive day was the day I appreciated the least. Looking back, I was pleased that I got a lot done, but that satisfaction was so much at a mental level. That mental satisfaction didn’t reach into my heart and make me feel like I could genuinely say I loved the day.

The days I loved most when I reflected back on them had more to do with being than with doing. All that was required for me to love the whole day was to recall one delightful event from it, and these events were usually very simple and not particularly effortful.

One Delightful Event

Even if most of the activities of a day were routine or so-so, if I experienced one delightful event during the day, I would always feel a heartfelt sense of appreciation for the day when I reflected back on it afterwards. So my appreciation ultimately came down to simple moments.

Mostly these delightful events involved something new – usually not wildly different but with just enough novelty to create a special memory for that day.

Here are some examples of small but delightful events that made me reflect back on the day with feelings of love and appreciation:

  • Running a different route than I’d run before, along a new street that had just recently been paved on the western edge of the city. The streetlights were working, but the sidewalks and landscaping hadn’t been added yet. It felt special to be one of the first people to run down a new road that wasn’t open to car traffic, like it was my own private running route. On one side was a wall with newly built houses behind it, and on the other side was open desert. (See the photo below, taken during my first run down that street.)
  • Playing some new video games with Rachelle, especially A Short Hike and Untitled Goose Game – the goose game made us laugh a lot.
  • Going to the Apple Store with Rachelle, getting new Apple Watches, and chatting with the employees. The store had been closed for many weeks and just reopened last week, so the vibe was upbeat and happy.
  • Returning a monitor that broke (while under warranty) to that same Apple Store and getting a replacement for it, which made me appreciate it more.
  • Going for a longer than usual run with new running shoes one morning.
  • Cleaning up some parts of the house to restore them to a nicer state of cleanliness and order.
  • Watching Cobra Kai with Rachelle. The show is set in an area where I used to live, and it reconnected me with fond memories of martial arts training.
  • Discovering some useful insights during journaling sessions.
  • Participating in a weekend intensive with a coaching group on Zoom.
  • Connecting with CGCers during coaching calls.
  • Attending a live script reading of The Princess Bride with many of the original cast members, along with more than 100K other people.
  • Listening to Kevin Smith’s Tough Sh*t audiobook, laughing a lot, and loving all the geeky references.
  • Yummy sex.
  • Having a good dentist appointment and chatting with the hygienist. (I actually like going to the dentist since the people there are so friendly and down-to-earth.)
  • One day when I exercised for 150+ minutes – it felt good to move a lot.
  • Attending a diversity committee call for the Transformational Leadership Council – nice to connect with like-minded friends who care.
  • Watching the final episode of The Good Place with Rachelle and seeing her getting teary-eyed at the end.

September was a pretty happy month for me, probably because I paid extra attention to happiness. I realized that big accomplishments don’t fuel my happiness as much as I thought, but small delights do.

A nice morning run, an insightful journaling session, a fun video game – these are all good ways to create a day I’ll appreciate. But what seems to help the most is including some form of novelty in a day. Newness made me happier than routine.

It’s more special to play a new video game than one I’ve played many times before. It’s more special to try a new brand of running shoes that I’ve never worn before. It’s more special to go a slightly different direction instead of following a familiar route.

It’s okay if my experiences are rooted to familiar places and situations, but one little twist in the direction of novelty somehow makes me appreciate the experience – and the day – more than I otherwise would.

Just running down a different street instead of running one of my standard routes can make a meaningful difference in how I feel about the whole day. I could have the laziest day ever, but if I just had one new experience that day, it elevated my relationship with the day. That surprised me. I didn’t think novelty was so meaningful.

Work-wise I felt better about the days when I didn’t use a system or routine to get things done. I had more appreciation for the days when I went with the flow of inspiration, especially when it led to engaging with work a bit differently. This makes me really curious about how to leverage this further. Would I be more productive if instead of trying to systematize my approach to work, I went in the opposite direction and did something to make each day truly unique?

Note that having a routine and embracing novelty are not necessarily contradictory approaches. You can follow a structure and still include some novelty, like how many movies adhere to genre standards and then try to add some unique twists. A good structure often becomes invisible, so you’ll probably notice and appreciate the novel aspects more.

What I gained from this 30-day experiment is a greater respect for small delights created through novelty. When I feel a nudge to lean in the direction of doing something new, I’m more likely to trust that impulse now. When I have that thought to run a different route one morning, I trust that it serves a good purpose. Doing something even slightly new makes the activity more memorable, and it’s the memory that I appreciate.

I’m less likely to appreciate a very routine day because the day is harder to remember. When reviewing my time log entries, it’s hard to recall the details of a day filled with familiar items, even when I have a written record of the activities for that day. When there’s even one item that’s semi-unique though, I somehow remember the day with a smile.

Another realization is that newness stimulates more growth. Running a familiar route isn’t as stimulating for my body and mind as running a new route. Would I improve faster if I ran different routes more often instead of sticking with my familiar favorites? Probably.

I encourage you to do your own time logging experiment for at least a month, so you can discover your own insights, which won’t necessarily align with mine. Some readers have started their own logging practices within the past few weeks, and they’ve been emailing me to say that they’re finding it valuable too.

Share Button

Covid: Growth in Covid cases ‘may be levelling off’

New infections might be rising more slowly than in previous weeks – but the R number remains above one.

Share Button